Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DR26FKN6K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,914
Award facts
- Contract value 100% obligated
- $4,914.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $4,914.02 delivery order to AmerisourceBergen Drug Corp on July 14, 2026, for Monovisc 88 mg/4 ml syringes. The order is placed under the DLA Troop Support Medical indefinite delivery contract, which supports pharmaceutical and medical supply distribution to military healthcare systems globally.
Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of July 15, 2026.
Quick answers
Who was awarded contract SPE2DR26FKN6K?
SPE2DR26FKN6K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 14, 2026.
How much is contract SPE2DR26FKN6K worth?
The government has obligated $4,914 on SPE2DR26FKN6K.
Is contract SPE2DR26FKN6K an order under another contract?
Yes. SPE2DR26FKN6K is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FKN6K competed?
The extent of competition for SPE2DR26FKN6K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award